This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kallinowski, F. Articles by Vaupel, P. Search for Related Content PubMed PubMed Citation Articles by Kallinowski, F. Articles by Vaupel, P.

Blood Flow, Metabolism, Cellular Microenvironment, and Growth Rate of Human Tumor Xenografts¹

Department of Radiation Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114 [F. K., P. O., P. V.], and Department of Applied Physiology, University of Mainz, D-6500 Mainz, Federal Republic of Germany [K. H. S., S. R., M. K., M. S.]

Better understanding of the micromilieu of human tumors in situ is mandatory for further improvement of diagnostic and therapeutic interventions. Since investigations of untreated tumors of a wide size range are precluded in humans for ethical reasons, size-dependent changes in the pathophysiology of primary and metastatic human tumors were studied using "tissue-isolated" xenografts in nude rats. Tumor types included lung and breast cancers, ovarian and thyroid carcinomas, uterus tumors, and melanomas. A 10-fold variation in weight-adjusted tumor perfusion indicated large variations in angiogenesis which were unrelated to tumor type. Flow values obtained were consistent with data from clinical observations and were comparable to that in isografted rodent tumors. Using actual consumption and supply rates, maximum oxygen and glucose uptake rates were calculated for each tumor type. The capacity to consume oxygen and glucose varied 9-fold and 4-fold, respectively. However, considering actual consumption rates, blood flow was the principal modulator of substrate supply and tumor metabolism in these human tumor xenografts. Consequently, therapeutically relevant parameters of the metabolic micromilieu largely depended on the efficacy of the tumor circulation. Hereby, high metabolic rates concomitant with high flow values coincided with rapid tumor growth. Thus, in order to design the best individualized therapy, flow-related data should supplement histological classification and clinical staging and grading. Further development of relatively noninvasive technologies (magnetic resonance imaging, magnetic resonance spectroscopy, or positron emission tomography) might permit such monitoring.

¹ Financial support from the "Gesellschaft der Goenner und Foerderer der Grundlagenforschung des Krebses" (Mainz, FRG) is gratefully acknowledged.

² To whom requests for reprints should be addressed, at Institute of Physiology and Pathophysiology, University of Mainz, Duesbergweg 6, D-6500 Mainz, Federal Republic of Germany.

Received 12/21/88. Revised 3/13/89. Accepted 4/ 5/89.

This article has been cited by other articles:

				G. Bodner, M. F. H. Schocke, F. Rachbauer, K. Seppi, S. Peer, A. Fierlinger, T. Sununu, and W. R. Jaschke Differentiation of Malignant and Benign Musculoskeletal Tumors: Combined Color and Power Doppler US and Spectral Wave Analysis Radiology, May 1, 2002; 223(2): 410 - 416. [Abstract] [Full Text] [PDF]

				M. Crowther, N. J. Brown, E. T. Bishop, and C. E. Lewis Microenvironmental influence on macrophage regulation of angiogenesis in wounds and malignant tumors J. Leukoc. Biol., October 1, 2001; 70(4): 478 - 490. [Abstract] [Full Text] [PDF]

				A. Ziegler, M. v. Kienlin, M. Decorps, and C. Remy High Glycolytic Activity in Rat Glioma Demonstrated in Vivo by Correlation Peak 1H Magnetic Resonance Imaging Cancer Res., July 1, 2001; 61(14): 5595 - 5600. [Abstract] [Full Text] [PDF]

				M. Hockel and P. Vaupel Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects J Natl Cancer Inst, February 21, 2001; 93(4): 266 - 276. [Abstract] [Full Text] [PDF]

				R. Zhou, N. Bansal, D. B. Leeper, and J. D. Glickson Intracellular Acidification of Human Melanoma Xenografts by the Respiratory Inhibitor m-Iodobenzylguanidine Plus Hyperglycemia: A 31P Magnetic Resonance Spectroscopy Study Cancer Res., July 1, 2000; 60(13): 3532 - 3536. [Abstract] [Full Text]

				G. Barnett, A.-M. Jakobsen, M. Tas, K. Rice, J. Carmichael, and J. C. Murray Prostate Adenocarcinoma Cells Release the Novel Proinflammatory Polypeptide EMAP-II in Response to Stress Cancer Res., June 1, 2000; 60(11): 2850 - 2857. [Abstract] [Full Text] [PDF]

				S. Walenta, M. Wetterling, M. Lehrke, G. Schwickert, K. Sundfør, E. K. Rofstad, and W. Mueller-Klieser High Lactate Levels Predict Likelihood of Metastases, Tumor Recurrence, and Restricted Patient Survival in Human Cervical Cancers Cancer Res., February 1, 2000; 60(4): 916 - 921. [Abstract] [Full Text]